Participation, yield, and interval carcinomas in three rounds of biennial FIT-based colorectal cancer screening

Cancer Epidemiology

Volumn 39, Issue 3, 2015, Pages 388-393

  Stegeman, I ^a   van Doorn, S C ^a   Mundt, M W ^b   Mallant Hent, R C ^b   Bongers, E ^c   Elferink, M A G ^d   Fockens, P ^a   Stroobants, A K ^a   Bossuyt, P M ^a   Dekker, E ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Academic Medical Centre ^*  (Netherlands)

^c Foundation of Population screening Mid West   (Netherlands)

^d Department of Research and Registration   (Netherlands)

Author keywords

Colorecal cancer; FIT; Prevention; Screening

Indexed keywords

BISACODYL; GUAIAC; HEMOGLOBIN; MACROGOL; MOVIPREP;

ADULT; ADVANCED CANCER; AGED; ARTICLE; AUTOANALYSIS; CANCER REGISTRY; CANCER SCREENING; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; DIAGNOSTIC VALUE; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NETHERLANDS; OCCULT BLOOD TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; CARCINOMA; CHEMISTRY; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; FECES; MIDDLE AGED; OCCULT BLOOD; PROCEDURES; SENSITIVITY AND SPECIFICITY; UTILIZATION;

AGED; CARCINOMA; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; OCCULT BLOOD; SENSITIVITY AND SPECIFICITY;

EID: 84929954319     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2015.03.012     Document Type: Article

References (16)

1. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2006, 18:581-592.
2. Van Rossum L.G., van Rijn A.F., Laheij R.J., van Oijen M.G., Fockens P., van Krieken H.H., et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008, 135:82-90. 10.1053/j.gastro.2008.03.040.
3. Winawer S.J., Zauber A.G., Ho M.N., O'Brien M.J., Gottlieb L.S., Sternberg S.S., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The national polyp study workgroup. N Engl J Med 1993, 329:1977-1981.
4. Libby G., Brewster D.H., McClements P.L., Carey F.A., Black R.J., Birrell J., et al. The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study. Br J Cancer 2012, 107:255-259.
5. Denters M.J., Deutekom M., Bossuyt P.M., Stroobants A.K., Fockens P., Dekker E. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer. YGAST 2011, 1-28.
6. Van Roon A.H.C., Goede S.L., van Ballegooijen M., van Vuuren A.J., Looman C.W.N., Biermann K., et al. Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut 2012, 10.1136/gutjnl-2011-301583.
7. De wijkerslooth T.R., Stoop E.M., Bossuyt P.M., Meijer G.A., van Ballegooijen M., van Roon A.H.C., et al. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol 2012, 107(October (10)):1570-1578.
8. Crotta S., Segnan N., Paganin S., Dagnes B., Rosset R., Senore C. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test. Clin Gastroenterol Hepatol 2012, 10:633-638.
9. Stegeman I., de Wijkerslooth T.R., Mallant-Hent R.C., de Groot K., Stroobants A.K., Fockens P., et al. Implementation of population screening for colorectal cancer by repeated fecal immunochemical test (FIT): third round. BMC Gastroenterol 2012, 12:73.
10. Edge S.B., Compton C.C. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010, 17:1471-1474.
11. Sanduleanu S., Le Clercq C.M.C., Dekker E., Meijer G.a., Rabeneck L., Rutter M.D., et al. Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature. Gut 2014, 1-11. 10.1136/gutjnl-2014-307992.
12. Dashwood R.H. Early detection and prevention of colorectal cancer (review). Oncol Rep 1999, 6:277-281.
13. Steele R.J.C., McClements P.L., Libby G., Black R., Morton C., Birrell J., et al. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut 2009, 58:530-535.
14. Kronborg O., Fenger C., Olsen J., Jørgensen O.D., Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996, 348:1467-1471.
15. Gill M.D., Bramble M.G., Rees C.J., Lee T.J.W., Bradburn D.M., Mills S.J. Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme. Br J Cancer 2012, 107:417-421.
16. Morris E.J.A., Whitehouse L.E., Farrell T., Nickerson C., Thomas J.D., Quirke P., et al. A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme. Br J Cancer 2012, 107:757-764.